<DOC>
	<DOCNO>NCT00827489</DOCNO>
	<brief_summary>The purpose study assess safety tolerability ascend single oral dos HTC-867 healthy young elderly subject . This study also evaluate way drug enters leave blood tissue time drug act body fast fed state .</brief_summary>
	<brief_title>Study Evaluating HTC-867 Healthy Young Elderly Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion : 1 . Men woman nonchildbearing potential ( WONCBP ) age 18 50 year 65 great inclusive screening . WONCBP may include either surgically sterile ( hysterectomy and/or oophorectomy ) postmenopausal ≥1 year ( folliclestimulating hormone [ FSH ] ≥38 mIU/mL ) must negative pregnancy test result within 48 hour administration study drug . Women surgically sterile must provide documentation procedure operative report ultrasound scan . Sexually active men must agree use medically acceptable form contraception study continue 12 week study drug administration . 2 . Healthy determine investigator basis screen evaluation . 3 . The elderly subject must generally healthy , may enrol stable , chronic illness well control interfere primary objective study . Subjects may include clinically important deviation normal limit medical history , physical examination finding , vital sign measurement , 12lead electrocardiogram ( ECGs ) , clinical laboratory test result associate stable , chronic , wellcontrolled medical condition , long deviation meet state specific criterion exclusion Exclusion : 1 . Presence history disorder may prevent successful completion study . 2 . History cardiac disorder ( hypertension ) include limited valvular disease , congestive heart failure , angina pectoris , myocardial infarction , arrhythmia . 3 . History vertigo .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>schizophrenia</keyword>
</DOC>